Annual report pursuant to Section 13 and 15(d)

Summary of Significant Accounting Policies (Tables)

v3.25.0.1
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2024
Accounting Policies [Abstract]  
Schedule of Other Receivables

 

 

As of

 

 

 

December 31, 2024

 

 

December 31, 2023

 

Payroll tax withholding and exercise proceeds receivable

 

$

834

 

 

$

 

Construction receivable

 

 

4,584

 

 

 

6,480

 

Income tax receivable

 

 

1,864

 

 

 

3,051

 

Insurance receivable

 

 

4,250

 

 

 

3,686

 

Other

 

 

1,986

 

 

 

1,497

 

Total other receivables

 

$

13,518

 

 

$

14,714

 

Schedule of Inventory

Inventory for the periods presented is as follows:

 

 

As of

 

 

 

December 31, 2024

 

 

December 31, 2023

 

Chemical washing solutions

 

$

5,831

 

 

$

9,135

 

Other

 

 

14

 

 

 

-

 

Total inventory, gross

 

 

5,845

 

 

 

9,135

 

Reserve for obsolescence

 

 

(117

)

 

 

(183

)

Total inventory, net

 

$

5,728

 

 

$

8,952

 

Schedule of Composition of Revenue

The following table summarizes the composition of our net revenues for the periods presented:

 

 

Year Ended December 31,

 

 

 

2024

 

 

2023

 

 

2022

 

Recognized over time

 

$

734,235

 

 

$

659,612

 

 

$

593,067

 

Recognized at a point in time

 

 

260,034

 

 

 

267,067

 

 

 

282,424

 

Other revenue

 

 

458

 

 

 

391

 

 

 

1,015

 

Net revenues

 

$

994,727

 

 

$

927,070

 

 

$

876,506

 

Schedule of Reconciliations of Numerators and Denominators of Basic and Diluted Earnings Per Share

Reconciliations of the numerators and denominators of the basic and diluted earnings per share calculations for the periods presented are as follows:

 

 

Year Ended December 31,

 

 

 

2024

 

 

2023

 

 

2022

 

Numerator:

 

 

 

 

 

 

 

 

 

Net income

 

$

70,239

 

 

$

80,130

 

 

$

112,900

 

 

 

 

 

 

 

 

 

 

Denominator:

 

 

 

 

 

 

 

 

 

Weighted-average common shares outstanding - basic

 

 

320,031,984

 

 

 

311,035,122

 

 

 

303,372,095

 

Effect of potentially dilutive securities:

 

 

 

 

 

 

 

 

 

Stock options

 

 

7,694,810

 

 

 

16,778,290

 

 

 

23,617,488

 

Restricted stock units

 

 

1,764,137

 

 

 

396,177

 

 

 

555,495

 

Employee stock purchase plan

 

 

22,301

 

 

 

30,015

 

 

 

15,329

 

Weighted-average common shares outstanding - diluted

 

 

329,513,232

 

 

 

328,239,604

 

 

 

327,560,407

 

 

 

 

 

 

 

 

 

 

Earnings per share - basic

 

$

0.22

 

 

$

0.26

 

 

$

0.37

 

Earnings per share - diluted

 

$

0.21

 

 

$

0.24

 

 

$

0.34

 

Schedule of Antidilutive Shares Excluded from Computation of Diluted Earnings Per Share

The following potentially dilutive shares were excluded from the computation of diluted earnings per share for the periods presented because including them would have been antidilutive:

 

 

Year Ended December 31,

 

 

 

2024

 

 

2023

 

 

2022

 

Stock options

 

 

4,480,312

 

 

 

3,457,404

 

 

 

2,204,216

 

Restricted stock units

 

 

350,326

 

 

 

184,619

 

 

 

62,140

 

Employee stock purchase plan

 

 

49,859

 

 

 

53,408

 

 

 

49,645